This innovative platform can be used in conjunction with next-generation sequencing (NGS) to isolate monoclonal antibodies (mAbs) with paired heavy chain and light chain from a wide range of animals, including humans, rabbits, rats, mice, chickens, camelids, sheep, primates, dogs, cows, and so on.

2Principal Attributes and Benefits of the Anti-GlyTM Platform

3a wide variety of glycoprotein production systems, such as yeast, mammalian, insect, and plant cells in addition to Escherichia coli.

4Different screening techniques to find anti-glycoprotein antibodies

5Various species are accessible

6High throughput and sensitivity

7economical and quick turnaround
For more: https://www.creative-biolabs.com/glycoprotein/anti-glycoprotein-antibody-development.htm